FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

331849001: Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3692860012 Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3692861011 Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream est un(e) (attribut) Betamethasone and fusidic acid only product in cutaneous dose form true Inferred relationship Some
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream Plays role Antibacterial therapeutic role (role) true Inferred relationship Some
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream est un(e) (attribut) Product containing betamethasone and fusidic acid (medicinal product) false Inferred relationship Some
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream a pour principe actif (attribut) Betamethasone false Inferred relationship Some
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream a pour principe actif (attribut) Adrenal hormone false Inferred relationship Some
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream a pour principe actif (attribut) Corticosterone false Inferred relationship Some
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream a pour principe actif (attribut) Adrenal hormone agent (substance) false Inferred relationship Some
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream a pour principe actif (attribut) Fusidic acid (substance) false Inferred relationship Some
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream a pour principe actif (attribut) Glucocorticoid hormone false Inferred relationship Some
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream a une forme pharmaceutique (attribut) Cutaneous AND/OR transdermal dosage form false Inferred relationship Some
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream a une forme pharmaceutique (attribut) Cream false Inferred relationship Some
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream a une forme pharmaceutique (attribut) Cutaneous cream true Inferred relationship Some
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream est un(e) (attribut) Product containing fusidic acid in topical dosage form (medicinal product form) false Inferred relationship Some
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream Has precise active ingredient Fusidic acid (substance) true Inferred relationship Some 2
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream Has precise active ingredient Betamethasone valerate (substance) true Inferred relationship Some 1
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream Count of base of active ingredient deux false Inferred relationship Some
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream Has concentration strength denominator value un false Inferred relationship Some 2
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream Has basis of strength substance (attribute) Fusidic acid (substance) true Inferred relationship Some 2
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream Has concentration strength numerator value (attribute) 20 (qualifier value) false Inferred relationship Some 2
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream Has concentration strength denominator unit g true Inferred relationship Some 2
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream Has concentration strength denominator unit g true Inferred relationship Some 1
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream Has concentration strength numerator unit milligram (qualifier value) true Inferred relationship Some 1
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream Has basis of strength substance (attribute) Betamethasone true Inferred relationship Some 1
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream Has concentration strength numerator unit milligram (qualifier value) true Inferred relationship Some 2
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream est un(e) (attribut) Product containing betamethasone valerate in topical dosage form (medicinal product form) false Inferred relationship Some
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream Has concentration strength numerator value (attribute) un false Inferred relationship Some 1
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream Has concentration strength denominator value un false Inferred relationship Some 1

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start